|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Mirum Pharmaceuticals, Inc. (MIRM) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
53,602,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Mirum Pharmaceuticals is a biopharmaceutical company focused on the identification, acquisition, development and commercialization of therapies for rare and orphan diseases. Co.'s focus is the development and commercialization of LIVMARLI® (maralixibat) oral solution (Livmarli) and volixibat. Livmarli is an oral solution approved as a once daily medicine for cholestatic pruritus in patients with Alagille syndrome one year of age and older. Co.'s second product candidate, volixibat, an oral, minimally-absorbed agent designed to inhibit ileal bile acid transporter, for the treatment of adult patients with cholestatic liver diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
4,000 |
6,910 |
175,963 |
175,963 |
| Total Buy Value |
$101,200 |
$183,553 |
$4,703,025 |
$4,703,025 |
| Total People Bought |
1 |
2 |
2 |
2 |
| Total Buy Transactions |
2 |
3 |
8 |
8 |
| Total Shares Sold |
14,902 |
26,974 |
84,524 |
431,922 |
| Total Sell Value |
$388,623 |
$737,972 |
$2,392,140 |
$9,495,201 |
| Total People Sold |
5 |
5 |
6 |
8 |
| Total Sell Transactions |
6 |
12 |
22 |
30 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bjerkholt Eric |
CHIEF FINANCIAL OFFICER |
• – – |
2024-03-27 |
4 |
B |
$24.80 |
$49,600 |
D/D |
2,000 |
14,000 |
0.01 |
- |
|
| Radovich Peter |
PRESIDENT AND COO |
• – – |
2024-03-25 |
4 |
S |
$25.80 |
$111,017 |
D/D |
(4,303) |
29,013 |
|
- |
|
| Bjerkholt Eric |
CHIEF FINANCIAL OFFICER |
• – – |
2024-03-18 |
4 |
B |
$25.80 |
$51,600 |
D/D |
2,000 |
12,000 |
0.01 |
- |
|
| Peetz Christopher |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-02 |
4 |
S |
$26.19 |
$157,491 |
D/D |
(6,013) |
104,112 |
|
- |
|
| Vig Pamela |
CHIEF SCIENTIFIC OFFICER |
• – – |
2024-02-02 |
4 |
S |
$26.19 |
$31,797 |
D/D |
(1,214) |
28,691 |
|
- |
|
| Radovich Peter |
PRESIDENT AND COO |
• – – |
2024-02-02 |
4 |
S |
$26.19 |
$46,883 |
D/D |
(1,790) |
34,695 |
|
- |
|
| Longpre Lara |
CHIEF DEVELOPMENT OFFICER |
• – – |
2024-02-02 |
4 |
S |
$26.19 |
$22,184 |
D/D |
(847) |
104,407 |
|
- |
|
| Howe Jolanda |
SVP, GLOBAL CONTROLLER |
• – – |
2024-02-02 |
4 |
S |
$26.19 |
$19,251 |
D/D |
(735) |
1,759 |
|
- |
|
| Howe Jolanda |
SVP, GLOBAL CONTROLLER |
• – – |
2024-01-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,772 |
2,494 |
|
- |
|
| Peetz Christopher |
PRESIDENT AND CEO |
• • – |
2024-01-08 |
4 |
S |
$28.03 |
$146,033 |
D/D |
(5,209) |
110,125 |
|
- |
|
| Longpre Lara |
CHIEF DEVELOPMENT OFFICER |
• – – |
2024-01-08 |
4 |
S |
$28.04 |
$28,568 |
D/D |
(1,019) |
105,254 |
|
- |
|
| Vig Pamela |
HEAD OF RESEARCH & DEVELOPMENT |
• – – |
2024-01-08 |
4 |
S |
$28.03 |
$39,472 |
D/D |
(1,408) |
29,905 |
|
- |
|
| Radovich Peter |
CHIEF OPERATING OFFICER |
• – – |
2024-01-08 |
4 |
S |
$28.03 |
$39,473 |
D/D |
(1,408) |
36,485 |
|
- |
|
| Howe Jolanda |
SVP, GLOBAL CONTROLLER |
• – – |
2024-01-08 |
4 |
S |
$28.04 |
$14,803 |
D/D |
(528) |
722 |
|
- |
|
| Howe Jolanda |
SVP, GLOBAL CONTROLLER |
• – – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
|
- |
|
| Howe Jolanda |
SVP, Global Controller |
• – – |
2023-12-05 |
4 |
S |
$32.40 |
$81,000 |
D/D |
(2,500) |
0 |
|
- |
|
| Howe Jolanda |
SVP, Global Controller |
• – – |
2023-12-05 |
4 |
OE |
$2.94 |
$7,350 |
D/D |
2,500 |
2,500 |
|
- |
|
| Radovich Peter |
Chief Operating Officer |
• – – |
2023-11-10 |
4 |
A |
$22.29 |
$4,859 |
D/D |
218 |
37,893 |
|
- |
|
| Longpre Lara |
Chief Development Officer |
• – – |
2023-11-10 |
4 |
A |
$22.29 |
$9,673 |
D/D |
434 |
106,273 |
|
- |
|
| Vig Pamela |
Head of Research & Development |
• – – |
2023-11-10 |
4 |
A |
$22.29 |
$11,745 |
D/D |
527 |
31,313 |
|
- |
|
| Heron Patrick J |
Director |
– • – |
2023-11-09 |
4 |
B |
$28.30 |
$82,353 |
I/I |
2,910 |
161,963 |
2.1 |
- |
|
| Grey Michael G |
Director |
– • – |
2023-09-14 |
4 |
AS |
$32.00 |
$454,912 |
D/D |
(14,216) |
0 |
|
- |
|
| Grey Michael G |
Director |
– • – |
2023-09-14 |
4 |
OE |
$2.94 |
$41,738 |
D/D |
14,216 |
14,216 |
|
- |
|
| Heron Patrick J |
Director |
– • – |
2023-09-13 |
4 |
B |
$31.02 |
$81,425 |
I/I |
2,625 |
159,053 |
2.1 |
- |
|
| Grey Michael G |
Director |
– • – |
2023-09-13 |
4 |
AS |
$32.00 |
$12,544 |
D/D |
(392) |
0 |
|
- |
|
191 Records found
|
|
Page 1 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
